Weidai Stock Forecast, Price & News

Weidai's stock was trading at $1.46 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, WEI shares have decreased by 39.6% and is now trading at $0.8815.
View which stocks have been most impacted by COVID-19.

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Weidai in the last year. There are currently 2 sell ratings for the stock, resulting in a consensus recommendation of "Sell."
View analyst ratings for Weidai.

Weidai is scheduled to release its next quarterly earnings announcement on Wednesday, September 30th 2020.
View our earnings forecast for Weidai.

Weidai Ltd (NYSE:WEI) announced its quarterly earnings data on Wednesday, May, 27th. The company reported ($1.14) earnings per share for the quarter, missing the Zacks' consensus estimate of $1.55 by $2.69. The business had revenue of $101.54 million for the quarter. Weidai had a net margin of 7.55% and a return on equity of 7.93%.
View Weidai's earnings history.

2 equities research analysts have issued 12-month target prices for Weidai's shares. Their forecasts range from $5.40 to $5.40. On average, they expect Weidai's share price to reach $5.40 in the next year. This suggests a possible upside of 512.6% from the stock's current price.
View analysts' price targets for Weidai.

Weidai saw a decline in short interest in September. As of September 15th, there was short interest totaling 22,000 shares, a decline of 32.5% from the August 31st total of 32,600 shares. Based on an average trading volume of 43,300 shares, the short-interest ratio is currently 0.5 days.
View Weidai's Short Interest.

Some companies that are related to Weidai include CNFinance (CNF), 9F (JFU), Jiayin Group (JFIN), Security National Financial (SNFCA), Elevate Credit (ELVT), Velocity Financial (VEL), On Deck Capital (ONDK), X Financial (XYF), Consumer Portfolio Services (CPSS), Fincera (YUANF), Golden Bull (DNJR), Golden Bull (BTBT), Medallion Financial (MFIN), Mogo Finance Technology (MOGO) and Senmiao Technology (AIHS).
View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Weidai investors own include AbbVie (ABBV), Carnival (CCL), Energy Transfer LP Unit (ET), American Airlines Group (AAL), Baidu (BIDU), Corbus Pharmaceuticals (CRBP), NIO (NIO), Ovid Therapeutics (OVID), Primo Water (PRMW) and Voyager Therapeutics (VYGR).

(WEI) raised $45 million in an initial public offering on Thursday, November 15th 2018. The company issued 4,500,000 shares at $9.00-$11.00 per share. Morgan Stanley and Citigroup served as the underwriters for the IPO and AMTD was co-manager.

Weidai trades on the New York Stock Exchange (NYSE) under the ticker symbol "WEI."

Shares of WEI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of WEI stock can currently be purchased for approximately $0.88.

Weidai has a market capitalization of $62.10 million and generates $482.27 million in revenue each year. The company earns $36.43 million in net income (profit) each year or $0.52 on an earnings per share basis. Weidai employs 6,970 workers across the globe.

The official website for Weidai is www.weidai.com.cn.

Weidai's mailing address is NO. 9 BAIYUN ROAD SHANGCHENG DISTRICT, HANGZHOU F4, 310000. The company can be reached via phone at 86-571-5697-9013 or via email at [email protected]